Back to today’s briefing

Story perspectives

Metformin May Lower Non-Melanoma Skin Cancer Risk

1/25/2025

35 5

Summary

Story summary

A groundbreaking study suggests that metformin, commonly used to treat diabetes, could lower the risk of non-melanoma skin cancers, particularly basal and squamous cell types. While metformin users generally showed a reduced risk, Black individuals did not benefit against squamous cell cancer. This discovery opens the door for further research into metformin's preventive potential.

1 of 1

Story summary

A groundbreaking study suggests that metformin, commonly used to treat diabetes, could lower the risk of non-melanoma skin cancers, particularly basal and squamous cell types. While metformin users generally showed a reduced risk, Black individuals did not benefit against squamous cell cancer. This discovery opens the door for further research into metformin's preventive potential.